Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Nippon Shinyaku and Atsena Therapeutics Enters into Collaboration for ATSN-101 in the U.S. and Japan
Thursday, November 14, 2024Nippon Shinyaku and Atsena Therapeutics have entered into an exclusive licencing agreement focused on the commercialisation and development of ATSN an investigational gene therapy for Leber congenital amaurosis LCA caused by biallelic mutations in GU...
BioNTech Acquires Biotheus to Develop Novel Antibody Therapies
Thursday, November 14, 2024BioNTech has entered into a definitive agreement to acquire Biotheus with the aim of enhancing the discovery and development of novel antibody therapies to address unmet medical needs in oncology and inflammatory diseases
Daiichi Sankyo and AstraZeneca Submits New BLA for Accelerated Approval of Non-Small Cell Lung Cancer (NSCLC)
Wednesday, November 13, 2024Daiichi Sankyo and AstraZeneca have submitted a Biologics License Application BLA for accelerated approval in the US for datopotamab deruxtecan DatoDXd as a treatment for adult patients with advanced or metastatic epidermal growth factor receptor EGF...
Apollo Therapeutics and Sunshine Lake Pharma Enters into Exclusive License Agreement for APL-18881
Wednesday, November 13, 2024Apollo Therapeutics has signed an exclusive license agreement with Sunshine Lake Pharma APL HEC is designed to simultaneously activate FGF and GLP receptors with both pathways showing potential for treating a variety of metabolic diseases
QIAGEN Enters into Collaboration with McGill University to Advance Microbiome Research
Wednesday, November 13, 2024QIAGEN has announced a threeyear collaboration with McGill Universitys Centre for Microbiome Research to support advances in microbiome research This collaboration is set to aid deeper insights into microbial ecosystems and their potential impact on...
Insilico Medicine Reports Positive Topline Results for AI-Developed ISM001-055 in Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Wednesday, November 13, 2024Insilico Medicine has announced encouraging topline results from its Phase IIa trial of ISM Idiopathic Pulmonary Fibrosis IPF is a chronic lung disease causing irreversible lung function decline affecting around million people globally
Actuate Therapeutics Receives FDA Rare Paediatric Disease Designation for Elraglusib in Ewing Sarcoma Treatment
Wednesday, November 13, 2024Actuate Therapeutics has been granted a rare paediatric disease designation by the US Food and Drug Administration FDA for its investigational treatment Ewing sarcoma is a rare aggressive cancer that typically affects children and adolescents primari...
Zai Lab and argenx Secure Chinese Approval for VYVGART Hytrulo in Treating CIDP
Tuesday, November 12, 2024Zai Lab and argenx have announced that Chinas National Medical Products Administration NMPA has approved the supplemental Biologics License Application sBLA for VYVGART Hytrulo mg ml per vial
BrainStorm Enters into Partnership with Pluri on Phase 3b Manufacturing for NurOwn® Trial
Tuesday, November 12, 2024BrainStorm Cell Therapeutics has signed a Memorandum of Understanding MOU with Pluri to support its upcoming Phase b trial for NurOwn a treatment under investigation for amyotrophic lateral sclerosis ALS
Neurizon Receives Positive EMA Opinion for NUZ-001 Orphan Designation
Tuesday, November 12, 2024Neurizon Therapeutics has received a positive opinion from the European Medicines Agency EMA for Orphan Medicinal Product Designation OMPD for its lead drug candidate NUZ targeting Amyotrophic Lateral Sclerosis ALS
